Table 5.
Geometric mean pharmacokinetic parameters (A) and evaluation of food effect (B) for the prodrug and OBE002 in plasma
A. Geometric mean pharmacokinetic parameters | |||||||
---|---|---|---|---|---|---|---|
Geometric means of Prodrug | Geometric means of OBE002 | ||||||
Parameter (unit) | Prodrug | Prodrug | Prodrug | Prodrug | Prodrug | Prodrug | |
100 mg | 300 mg | 1000 mg | 100 mg | 300 mg | 1000 mg | ||
N = 6 | N = 6 | N = 6 | N = 6 | N = 6 | N = 6 | ||
C max (ng ml –1 ) | Fed / Fasted | 0.69 | 0.59 | 4.53 | 26.8 | 100.5 | 567.2 |
0.20 | 0.85 | 3.10 | 31.3 | 142.2 | 671.6 | ||
AUC 0–24h (h × ng ml –1 ) | Fed / Fasted | 0.36a | 1.53 | 9.83 | 313.0 | 1079.1 | 6411.2 |
0.13b | 1.43 | 6.06 | 232.8 | 1052.7 | 5267.1 | ||
AUC 0–t (h × ng ml –1 ) | Fed / Fasted | 0.36a | 1.53 | 9.83 | 335.9 | 1201.7 | 6874 |
0.13b | 1.43 | 6.06 | 232.8 | 1052.7 | 5267.1 | ||
AUC 0–inf (h × ng ml –1 ) | Fed / Fasted | 1.47c | 2.38d | 10.67 | 402.5d | 1579.5d | 8059.3 |
‐ | 1.56b | 6.39 | 316.3 | 1559.1 | 7177.7 |
B. Evaluation of food effect | |||||||
---|---|---|---|---|---|---|---|
Prodrug (fed vs. fasted) | OBE002 (fed vs. fasted) | ||||||
Parameter | No. of subjects/observations | Estimate | 90% CI | No. of subjects/ observations | Estimate | 90% CI | |
C max | 17/28 | 1.20 | 0.75–1.92 | 17/34 | 0.80 | 0.68–0.94 | |
AUC 0–24h | 17/28 | 1.55 | 0.98–2.44 | 17/34 | 1.06 | 0.95–1.18 | |
AUC 0–t | 17/28 | 1.55 | 0.98–2.44 | 17/34 | 1.06 | 0.95–1.18 | |
AUC 0–inf | 17/20 | 1.84 | 1.55–2.17 | 17/32 | 1.15 | 1.07–1.24 |
N = number of subjects in cohort;
Four missing values;
Two missing values;
Five missing values;
One missing value;
CI = confidence interval